OS Therapies Inc 10-Q

Item 1. Legal Proceedings. We are not currently a party to any pending or threatened legal proceedings other than the arbitration proceeding described below. On April 12, 2024, Noble Capital Markets, Inc. (“Noble”) filed a Demand for Arbitration against us in JAMS, claiming that we breached the anti-dilution provision in the parties’ advisory agreement by not issuing to Noble an additional 474,134 shares of our common stock. In September 2024, we settled the matter with Noble in exchange for $50,000 and 320,033 shares of our common stock, which were issued during September 2024. See also Note 6 to our financial statements contained in Item 1 of Part I of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.